News | December 03, 2007

ACC Calls Members to Action, Stop Cuts

December 4, 2007 – American College of Cardiology CEO Jack Lewin has urged ACC members this week to let "their members of Congress know how bad things are getting” in regards to Medicare cuts.

The Senate Finance Committee will be introducing a package for Medicare physician payment cuts. In the “Lewin Report Blog,” Lewin warns that the ACC’s imaging accreditation and appropriateness criteria pilot may be included in this package.

“Congress will let the cuts go through, and come back to fix them in February or March,” said Lewin. “Congress is banking on the assumption that the cuts won’t cause physicians to change their practices and limit Medicare patients.”

Lewin suggests that funding for reversing these cuts may come from “Medicare Advantage insurance payments, which are 12 – 18 percent above regular Medicare.”

In any case, Lewin urges ACC member to contact Congressman, noting, “No matter how they fund reversing the cuts, we need to get the calls going this week.”

For more information: www.acc.org or www.lewinreport.acc.org


Related Content

News | Stents Drug Eluting

October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on ...

Home October 31, 2023
Home
News | Stents Drug Eluting

October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present ...

Home October 10, 2023
Home
News | Stents Drug Eluting

July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion ...

Home July 13, 2023
Home
News | Stents Drug Eluting

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

Home July 12, 2023
Home
News | Stents Drug Eluting

May 25, 2023 — First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic ...

Home May 25, 2023
Home
News | Stents Drug Eluting

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent ...

Home January 02, 2023
Home
News | Stents Drug Eluting

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

Home December 23, 2022
Home
News | Stents Drug Eluting

June 2, 2022 — Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced print ...

Home June 02, 2022
Home
News | Stents Drug Eluting

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced ...

Home February 16, 2022
Home
News | Stents Drug Eluting

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug ...

Home January 26, 2021
Home
Subscribe Now